Xenitra Limited has released a press release.
Appendix 4E and Annual Report
Earlier from Xenitra
- Xenitra Raises $1.5m to Accelerate High-Margin Sales Growth
- $5m Offtake Agreement Expands OTC-Medicine Business
- $12M offtake agreement with leading OTC-pharmaceutical
- $1.1m in OPAL-Tokenised Product Sales in First 7 Weeks